09-10, 11:45–12:15 (Europe/Istanbul), Hum+Trverse+Global 1 (ICC - B3 Floor - 3B/11)
•To design and optimize the CaHA-based biomaterial composition with adjustable rheological properties;
•To conduct in vitro biocompatibility testing;
•To fabricate 3D-printed implants using the material;
•To perform preclinical trials in animal models (paralysis and stenosis);
•To evaluate volume retention and tissue integration.
Development of a Bioactive Calcium Hydroxyapatite-Based Scaffold for Vocal Fold Tissue Regeneration
Dr. Dinara Toguzbayeva, Associate Professor at the Medical University of Almaty, Kazakhstan. She is a leading voice specialist, the founder of the first Voice Laboratory in Kazakhstan, and the country's first member of the European Union of Phoniatrics, having joined over 13 years ago. Her clinical and academic work focuses on phonosurgery and the in-depth study of voice disorders
- Practical Management Of Laryngopharyngeal Reflux Disease
- Salivary Control Disorders
- Vocal Fold Paresis. When I Couldn’t Get The Patient’s Voice Back
- Surgical Treatment In Bilateral Vocal Fold Paralysis
- Physiological Features And Phoniatric Aspects Of Traditional Singing Across The Turkic World: Problems And Solutions
He completed his medical education at İstanbul University Cerrahpaşa Faculty of Medicine, graduating in 1991. Doctorate/Residency: His specialty training (Doctora/Residency) was in the Department of Otorhinolaryngology at Trakya University Faculty of Medicine, which he completed in 1999. He was appointed Assistant Professor Doctor in the ENT Department in 2001. He achieved the rank of Associate Professor Doctor in 2006. He became a Professor Doctor in 2011. Chief of Department: He has served as the Head of the Department of Otorhinolaryngology at the Faculty of Medicine since July 3, 2023.
Otology and Hearing Studies: A significant portion of his research involves the ear, hearing, and the potential effects of medical treatments:
Ototoxicity: Investigating the protective and damaging effects of various substances on the ear, including:The protective effect of substances like ascorbic acid (Vitamin C) and magnesium against ototoxicity caused by drugs like cisplatin (a chemotherapy drug) or noise-induced hearing loss. Evaluating the possible ototoxic effects of topical applications like rifamycin, povidone-iodine, and antibiotics like azithromycin and clarithromycin, using electrophysiological tests such as Auditory Brainstem Responses (ABR) and Otoacoustic Emissions (OAE).
Hearing Disorders: Studies on the evaluation of hearing, including: Assessing hearing in children with conditions like Autism Spectrum Disorder using OAE and ABR. Research into the effects of middle ear conditions (like effusion and chronic suppurative otitis media) on hearing and the use of treatments like nebulized surfactant for otitis media with effusion.
Ear Surgery: Research related to surgical techniques, such as: Comparing the use of scapha vs. tragus cartilage grafts in cartilage tympanoplasty (eardrum repair) for morbidity and cosmetic results. Studies on the Combined Heermann and Tos (CHAT) technique in cholesteatoma surgery.